6505-01-272-2383
Ciprofloxacin Tablets
3 parts / 3 mfrs
| Part Number | CAGE | Manufacturer | RNCC | RNVC |
|---|---|---|---|---|
| NDC68084-0069-01 | 0A423 | Cardinal Health 100, Inc Dba Bindley Western Tennessee Div | 3 | 9 |
| NDC63739-0700-10 | 5STW2 | Mckesson Pharmacy Systems, Llc | 5 | 9 |
| NDC63139-0700-10 | 7K139 | Mckesson Medical-Surgical Inc. Dba Mckesson Medical-Surgical Inc | 3 | 2 |
Cardinal Health 100, Inc Dba Bindley Western Tennessee Div
CAGE 0A423Mckesson Pharmacy Systems, Llc
CAGE 5STW2Mckesson Medical-Surgical Inc. Dba Mckesson Medical-Surgical Inc
CAGE 7K139DEMIL
A
HMIC
Y
PMIC
A
ESD/EMI
| MRC | Requirement | Reply |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 1 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN HYDROCHLORIDE TABLETS 250MG I.S. 100S PG |
| FEAT | SPECIAL FEATURES | 100 TABLETS; UNIT DOSE. STORE AT USP CONTROLLED ROOM TEMPERATURE 20 T0 25 C (68 TO 77 F) EXCURSIONS PERMITTED TO 15 TO 30 C (59 TO 86 F). |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
Need full procurement data, packaging, and standardization info?
View Complete NSN Data on NSN LookupQuick Reference
About NSN 6505-01-272-2383
NSN 6505-01-272-2383 is a National Stock Number assigned to Ciprofloxacin Tablets. This NSN part number belongs to Federal Supply Class 6505 (DRUGS AND BIOLOGICALS) under Federal Supply Group 65 (MEDICAL, DENTAL, AND VETERINARY EQUIPMENT AND SUPPLIES). There are 3 part numbers associated with this NSN from 3 manufacturers.
To find the part number for NSN 6505-01-272-2383, refer to the part number cross-reference table above. Each part number is linked to its manufacturer through a CAGE (Commercial and Government Entity) code.